pH | 7.2 - 7.6 |
Osmolality | 285 - 315 mOsm/kg |
Volume | 500 mL |
Composition (100 mL) | |
Calcium chloride 2H2O | 0.048 g |
Potassium chloride | 0.075 g |
Sodium chloride | 0.640 g |
Magnesium chloride 6H2O | 0.030 g |
Sodium acetate 3H2O | 0.390 g |
Trisodium citrate 2H2O | 0.170 g |
Water for injection | q.s. |
Physiologic solution Isotonic to ocular tissues Preservative free Great for all ophthalmic surgical procedures Steam Sterilized 3-year shelf life |
Formula | C10F18 |
Density | 1,908 g/cm³ at 20 °C |
Refractive index | 1,313 at 20 ̊C |
Content | 100 % fluorinated perfluorocarbon |
Boiling point | 142 °C |
Packing | 5 ml in vial 7 ml in vial |
Ocudeka Decaline® 100% Fluorinated Perfluorocarbon Liquid For Retinal Surgery
|
|
Biocompatible Chemically and physiologically inert Efficient retinal unfolding and stabilization High specific density Steam Sterilized |
MİRAY MEDİKAL, founded in 2005 Bursa, is an innovative company that specializes in the field of Ophthalmology. We are the pioneers of the industry that invest in the ophthalmology sector in Bursa, considering both international developments and domestic needs.
Our products are manufactured using the highest levels of care and precision at our manufacturing facility with an indoor area of 2500 m² which is equipped with advanced technology machines and equipments. We offer the highest quality products and outstanding customer service with our authorized distributors throughout Turkey and the world.
Our Quality Management System is documented through certifications EN ISO 13485:2016 and 2195 CE that ensures that all products and processes meet and exceed prevailing standards.
Our experienced staff is aware of the importance of human life. So we believe
in continuous improvement without compromising on quality. We strive hard to make each and every modern technology and development within the easy reach of ophthalmic surgeons and eye care professionals and to provide them with the best quality and confidence.
The honest, principled and fast service concept of Miray Medikal proves that human
health is at the core of our business values. Thank you for your confidence and preference.
Hydroxypropyl Methylcellulose | 20 mg/ml (2.0%) of HPMC | |
Zero Shear Viscosity | 3.000 - 5.000 mPa.s | |
Osmolality | 270 - 400 mOsm/kg | |
pH | 6.8 - 7.6 | |
Volume | 2 mL | |
Packing | 10 per box | |
Composition (1 mL) | ||
Hydroxypropyl Methylcellulose | 20 mg | |
Calcium chloride 2H2O | 0.48 mg | |
Potassium chloride | 0.75 mg | |
Sodium chloride | 6.40 mg | |
Magnesium chloride 6H2O | 0.30 mg | |
Sodium acetate 3H2O | 3.90 mg | |
Trisodium citrate 2H2O | 1.70 mg | |
Water for injection | q.s |
Zero Shear Viscosity | 1000 cSt / 5000 cSt |
Refractive index | 1,401 - 1,405 at 25 °C |
Specific Gravity | 0,97 g/cm³ at 25 °C |
Packing | 10 ml in vial 15 ml in vial 10 ml in syringe |
Ocusil Silicone Oil 1000 cSt 10 ml / 15 ml Ocusil Silicone Oil 5000 cSt 10 ml / 15 ml | |
Ocusil® Silicone Oil is indicated for prolonged tamponade after surgical |
|
|
|
Excellent chemical purity Reliable long term tolerance High emulsification resistance Reduced incidence of complications Steam Sterilized |
Sodium Hyaluronate | 1.0% |
Molecular Weight | 3.8 - 4.5 million daltons |
Zero Shear Viscosity | 200.000 - 400.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Volume | 2.0 mL |
Composition (2mL) | |
Sodium Hyaluronate | 20 mg |
Sodium Chloride | 17 mg |
Disodium Hydrogen Phosphate | 1.126 mg |
Sodium Dihydrogen Phosphate | 0.090 mg |
Water for injection | q.s |
STERILE SODIUM HYALURONATE SOLUTION FOR INTRA-ARTICULAR INJECTION (ORTHOPEDICS) CrownFlex® is a sterile, non pyrogenic viscoelastic solution containing high-quality sodium hyaluronate derived from bio-fermentation. CrownFlex® is indicated on the patients with degenerative joint disease (osteoarthritis) for reducing mechanical stress on the joint and increasing the joint mobility due to its reliable lubrication and shock absorbing properties. |
Hydroxypropyl Methylcellulose | 24 mg/ml (2.4%) of HPMC | |
Zero Shear Viscosity | 6.000 - 8.000 mPa.s | |
Osmolality | 270 - 400 mOsm/kg | |
pH | 6.8 - 7.6 | |
Volume | 2 mL | |
Packing | 10 per box | |
Composition (1 mL) | ||
Hydroxypropyl Methylcellulose | 24 mg | |
Calcium chloride 2H2O | 0.48 mg | |
Potassium chloride | 0.75 mg | |
Sodium chloride | 6.40 mg | |
Magnesium chloride 6H2O | 0.30 mg | |
Sodium acetate 3H2O | 3.90 mg | |
Trisodium citrate 2H2O | 1.70 mg | |
Water for injection | q.s |
Technical Data | OCUBLU ® ILM Blue | OCUBLU ® ILM/ERM Blue |
pH | 6.0 - 8.0 | 6.0 - 8.0 |
Osmolality | 270 - 400 mOsm/kg | 270 - 400 mOsm/kg |
Storage | 10-30 ˚C | 10-30 ˚C |
Packing | 1 ml in vial / 5 per box 1 ml in syringe / 5 per box |
1 ml in vial / 5 per box
|
Ocublu ILM Blue is used to selectively stain and visualize Internal Limiting Membrane (ILM), facilitating removal of the tissue and reducing the risk of retinal damage. Ocublu ILM/ERM Blue has selective affinity for both Epiretinal Membrane (ERM) and Internal Limiting Membrane (ILM) which allows surgeons to clearly differentiate ILM, ERM and retina. |
||
|
Sodium Hyaluronate | 1.6% |
Molecular Weight | 2.9 - 3.8 million daltons |
Zero Shear Viscosity | 350.000 - 550.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Volume | 2.0 mL |
Composition (2mL) | |
Sodium Hyaluronate | 32 mg |
Sodium Chloride | 17 mg |
Disodium Hydrogen Phosphate | 1.126 mg |
Sodium Dihydrogen Phosphate | 0.090 mg |
Water for injection | q.s |
STERILE SODIUM HYALURONATE SOLUTION FOR INTRA-ARTICULAR INJECTION (ORTHOPEDICS) CrownFlex® is a sterile, non pyrogenic viscoelastic solution containing high-quality sodium hyaluronate derived from bio-fermentation. CrownFlex® is indicated on the patients with degenerative joint disease (osteoarthritis) for reducing mechanical stress on the joint and increasing the joint mobility due to its reliable lubrication and shock absorbing properties. |
Sodium Hyaluronate | 2.0% |
Molecular Weight | 1.8 - 2.5 million daltons |
Zero Shear Viscosity | 230.000 - 500.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Volume | 2.0 mL |
Composition (2mL) | |
Sodium Hyaluronate | 40 mg |
Sodium Chloride | 17 mg |
Disodium Hydrogen Phosphate | 1.126 mg |
Sodium Dihydrogen Phosphate | 0.090 mg |
Water for injection | q.s |
STERILE SODIUM HYALURONATE SOLUTION FOR INTRA-ARTICULAR INJECTION (ORTHOPEDICS) CrownFlex® is a sterile, non pyrogenic viscoelastic solution containing high-quality sodium hyaluronate derived from bio-fermentation. CrownFlex® is indicated on the patients with degenerative joint disease (osteoarthritis) for reducing mechanical stress on the joint and increasing the joint mobility due to its reliable lubrication and shock absorbing properties. |
Concentration | 10 mg/ml (1.0%) of sodium hyaluronate |
Molecular Weight | 3.8 - 4.5 million daltons |
Zero Shear Viscosity | 200.000 - 400.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Cannula | 27G |
Volume | 1 mL - 1.5 mL |
Composition (1 mL) | |
Sodium hyaluronate | 10 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Sodium Hyaluronate | 3.0% |
Molecular Weight | 1.8 - 2.5 million daltons |
Zero Shear Viscosity | 350.000 - 650.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Volume | 2.0 mL |
Composition (2mL) | |
Sodium Hyaluronate | 60 mg |
Sodium Chloride | 17 mg |
Disodium Hydrogen Phosphate | 1.126 mg |
Sodium Dihydrogen Phosphate | 0.090 mg |
Water for injection | q.s |
STERILE SODIUM HYALURONATE SOLUTION FOR INTRA-ARTICULAR INJECTION (ORTHOPEDICS) CrownFlex® is a sterile, non pyrogenic viscoelastic solution containing high-quality sodium hyaluronate derived from bio-fermentation. CrownFlex® is indicated on the patients with degenerative joint disease (osteoarthritis) for reducing mechanical stress on the joint and increasing the joint mobility due to its reliable lubrication and shock absorbing properties. |
|
Concentration | 14 mg/ml (1.4%) of sodium hyaluronate |
Molecular Weight | 2.9 - 3.8 million daltons |
Zero Shear Viscosity | 300.000 - 470.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Cannula | 27G |
Volume | 1 mL - 1.5 mL |
Composition (1 mL) | |
Sodium hyaluronate | 14 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Concentration | 16 mg/ml (1.6%) of sodium hyaluronate |
Molecular Weight | 2.9 - 3.8 million daltons |
Zero Shear Viscosity | 350.000 - 550.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Cannula | 27G |
Volume | 1 mL - 1.5 mL |
Composition (1 mL) | |
Sodium hyaluronate | 16 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Concentration | 18 mg/ml (1.8%) of sodium hyaluronate |
Molecular Weight | 2.9 - 3.8 million daltons |
Zero Shear Viscosity | 450.000 - 750.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Cannula | 27G |
Volume | 1 mL - 1.5 mL |
Composition (1 mL) | |
Sodium hyaluronate | 18 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Concentration | 30 mg/ml (3.0%) of sodium hyaluronate |
Molecular Weight | 1.8 - 2.5 million daltons |
Zero Shear Viscosity | 350.000 - 650.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
Storage | 2 - 25 ̊C |
pH | 6.8 - 7.6 |
Origin | Biofermentation |
Cannula | 25G |
Volume | 1 mL - 1.5 mL |
Composition (1 mL) | |
Sodium hyaluronate | 30 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Concentration | 14 mg/ml (1.4%) of sodium hyaluronate |
Origin | Biofermentation |
Molecular Weight | 3.8 - 4.5 million daltons |
Zero Shear Viscosity | 320.000 - 500.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
pH | 6.8 - 7.6 |
Cannula | 27G |
Volume | 1 ml |
Composition (1 mL) | |
Sodium hyaluronate | 14 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Concentration | 18 mg/ml (1.8%) of sodium hyaluronate |
Origin | Biofermentation |
Molecular Weight | 2.9 - 3.8 million daltons |
Viscosity | 450.000 - 750.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
pH | 6.8 - 7.6 |
Cannula | 27G |
Volume | 1 ml |
Composition (1 mL) | |
Sodium hyaluronate | 18 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Concentration | 20 mg/ml (2.0%) of sodium hyaluronate |
Origin | Biofermentation |
Molecular Weight | 1.8 - 2.5 million daltons |
Zero Shear Viscosity | 230.000 - 500.000 mPa.s |
Osmolality | 270 - 400 mOsm/kg |
pH | 6.8 - 7.6 |
Cannula | 25G |
Volume | 1 ml |
Composition (1 mL) | |
Sodium hyaluronate | 20 mg |
Sodium chloride | 8.5 mg |
Disodium hydrogen phosphate | 0.563 mg |
Sodium dihydrogen phosphate | 0.045 mg |
Water for injection | q.s |
Formula |
C34H24N6Na4O14S4 |
Concentration |
0,02%, 0,04%, 0,06% |
Packing |
1 ml in vial / 10 per box |
Ocublu-Try Trypan Blue 0.02% - 0.2 mg 1mL Ocublu-Try Trypan Blue 0.04% - 0.4 mg 1mL Ocublu-Try Trypan Blue 0.06% - 0.6 mg 1mL |
|
Ocublu-Try Trypan Blue® is a sterile intra-ocular solution which stains the anterior lens capsule to visualize the capsulorhexis during cataract surgery. |
|
|
|
Rapid and easy application |